The following codes are being added to Medicare MDR with a 10/1/20 effective date (effective 10/1/20...

Due to the COVID-19 pandemic, BCBSRI has extended all clinical authorization approvals by Prime Ther...

Effective May 1, 2020, Lifespan employee group will begin covering medical specialty drugs under the...

As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...

As part of the annual formulary development and management process, the next scheduled update of the...

As part of our standard formulary management process of implementing formulary updates twice per yea...

Effective December 1, 2019, BCBSRI will begin requiring prior authorization for an expanded list of ...

As of October 1, 2019, for commercial members, the drugs listed below will move from the specialty p...

Effective July 1, 2019, both PCSK-9 products for cholesterol management—Repatha and Praluent—became ...

Pharmacy benefit coverage for Commercial members will be updated effective May 1, 2019 to include co...

The BCBSRI Commercial formulary for April is now available. You can view the summary that provides d...

Consistent with our management practice, April 1, 2019 is the next scheduled update of the BCBSRI Co...

Effective April 1, 2019, coverage of Radicava will change from the specialty pharmacy benefit to the...

In order to meet these deadlines, all relevant clinical information must be provided at the time a d...

BCBSRI is informing the provider community about a recent CMS guideline change regarding opioid use ...

In our ongoing efforts to make high-quality and affordable healthcare available to our members, BCBS...

Consistent with our management practice, October 1, 2018 marked the next scheduled update of the BCB...

Effective October 1, 2018, the BCBSRI Pharmacy Formulary will be updated to remove the generic equiv...